Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | EPAS1 | Q99814 | 8/20 | 0.37 |
| ▸ | VEGFA | P15692 | 5/20 | 0.37 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | BCL9 | O00512 | 2/20 | 0.36 |
| ▸ | CTNNB1 | P35222 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23842815 | 0.88 | SLC6A4 (0.40) | MGLLEPAS1VEGFASLC6A2SLC6A4 | |
| Trifluoroacetic Acid SCHEMBL23830454 | 0.82 | SLC6A4 (0.51) | MGLLSLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830498 | 0.82 | EPHX2 (0.46) | — | |
| Trifluoroacetic Acid SCHEMBL23830676 | 0.77 | PGR (0.41) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830763 | 0.77 | GPR6 (0.51) | SLC6A4BCL9CTNNB1 | |
| Trifluoroacetic Acid SCHEMBL21590609 | 0.76 | SLC6A2 (0.49) | MGLLSLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23830859 | 0.76 | SLC6A2 (0.45) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL23850944 | 0.74 | PDE9A (0.44) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL24131316 | 0.73 | EPAS1 (0.42) | MGLLEPAS1VEGFAHAO1 | |
| SCHEMBL20165871 | 0.72 | SLC6A2 (0.48) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | SIRONAX LTD (KY) | 2021-09-23 | — | — | US | disclosed |
| CN-113302183-A | Cyclic ureas | 圣瑞诺有限公司 | 2021-08-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210292305-A1 | Cyclic Ureas | RIPK1, RIPK3, RIPK4 | MGLL 4549/4885EPAS1 312/4885VEGFA 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.